2nd H2020 Call for research on COVID-19 - detailed information for international participants
Deadline: 11 June 2020
The European Commission (EC) has launched a new call for expressions of interest (EoI) under Horizon 2020 for research into the COVID19. The new call for expressions of interest contributes to the Commission's €1.4 billion pledge to the Coronavirus Global Response initiative, launched by EC President Ursula von der Leyen on 4 May 2020.
The projects funded under this call should repurpose manufacturing for rapid production of vital medical supplies and equipment needed for testing, treatment and prevention, as well as develop medical technologies and digital tools to improve detection, surveillance and patients care.
The calls are open for international cooperation with legal entities from third countries, and/or regions including those not automatically eligible for funding.
The new call is the latest addition to a range of EU-funded research and innovation actions to fight the coronavirus, including notably the 1st call for EoI, the recent IMI COVID19 call, the EIC accelerator initiative to support SMEs innovation against the coronavirus pandemic, etc. The 2nd E.C. Call for EoI complements these earlier actions to develop diagnostics, treatments and vaccines by strengthening capacity to manufacture and deploying readily available solutions in order to rapidly address the pressing needs. It will also improve understanding of the behavioural and socio-economic impacts of the epidemic.
The new call will cover five areas with the following indicative budgets:
- Repurposing of manufacturing for vital medical supplies and equipment (€23 million)
- Medical technologies, Digital tools and Artificial Intelligence analytics to improve surveillance and care at high Technology Readiness Levels (€56 million)
- Behavioural, social and economic impacts of the outbreak responses (€20 million)
- Pan-European COVID-19 cohorts (€20 million)
- Collaboration of existing EU and international cohorts of relevance to COVID-19 (€3 million)
This call is not intended to support R&D to find new diagnostics, treatments or vaccines to fight against Sars-Cov-2 and COVID19, contrarily to previous initiatives.
Early measurable impact should be delivered by the projects to answer this call, typically with positive effects and useful outreach in the next first months. The threshold for evaluation will be stringent because even more excellence in this new phase of response against the pandemic is needed.
This call is indeed very open for International cooperation with non-EU partners, being legal entities of third countries and/or regions (see in General Annex A), encouraging international collaborations for a more global answer against COVID19.
Para investigadores de la Universidad Nacional de Colombia interesados en participar en la convocatoria: los trámites internos deben realizarse a través de la dirección de investigación y extensión de sede (o la instancia que haga sus veces) correspondiente.
Deadline: 11 June 2020
More information and resources
(Euraxess América Latina y el Caribe; Nobel Project; DSM/DNIL))
[Boletín SIUN 488, 28 de mayo de 2020]